ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 157 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2020. The put-call ratio across all filers is 1.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $34,000 | -40.4% | 26,444 | -19.4% | 0.00% | – |
| Q4 2021 | $57,000 | -18.6% | 32,802 | +2.2% | 0.00% | – |
| Q3 2021 | $70,000 | -50.0% | 32,094 | -20.0% | 0.00% | – |
| Q2 2021 | $140,000 | -62.0% | 40,133 | +7.7% | 0.00% | -100.0% |
| Q1 2021 | $368,000 | -2.4% | 37,276 | +7.2% | 0.00% | 0.0% |
| Q4 2020 | $377,000 | +40.7% | 34,757 | +33.8% | 0.00% | 0.0% |
| Q3 2020 | $268,000 | -43.6% | 25,973 | +14.1% | 0.00% | -66.7% |
| Q2 2020 | $475,000 | +289.3% | 22,755 | +82.1% | 0.00% | +200.0% |
| Q1 2020 | $122,000 | -50.2% | 12,499 | -41.3% | 0.00% | 0.0% |
| Q4 2019 | $245,000 | +89.9% | 21,284 | -9.8% | 0.00% | 0.0% |
| Q3 2019 | $129,000 | -55.4% | 23,600 | -2.8% | 0.00% | -50.0% |
| Q2 2019 | $289,000 | +102.1% | 24,280 | -11.0% | 0.00% | +100.0% |
| Q1 2019 | $143,000 | +68.2% | 27,276 | +0.9% | 0.00% | 0.0% |
| Q4 2018 | $85,000 | -26.7% | 27,046 | -4.6% | 0.00% | -50.0% |
| Q3 2016 | $116,000 | +9.4% | 28,344 | -15.4% | 0.00% | +100.0% |
| Q2 2016 | $106,000 | – | 33,496 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |